Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With Transfusion-dependent β-thalassemia
The goal of this clinical trial is to compare physical ability of patients with transfusion-dependent β-thalassemia to control subjects. The main question it aims to answer is: is there a difference in power output at first lactate threshold between patients with transfusion-dependent β-thalassemia and control subjects during maximal incremental exercise test. Participants will have to realise differents exams including measurement of body compposition, maximal incremental exercise test, vertical jump, vasoreactivity test, blood sampling, quality of life questionnaires and neuromuscular assessments.
• Patients aged 18 years or older
‣ Patients with transfusion-dependent β-thalassaemia (B0 or B+)
⁃ Patients who have undergone blood transfusions at intervals of between 1 and 8 weeks for at least 5 years.
⁃ Have given their free and informed written consent after being informed of the purpose of the study, its conduct and its risks.
⁃ Be affiliated with a social security scheme.
⁃ Not participating in any other interventional studies during the duration of this study
∙ Control subjects must meet all of the following criteria to participate in the study:
• Subject aged 18 years or older
• Matched in age and gender to a βTTD patient included in the study.
• Declaring to be free of known acute or chronic pathologies.
• Have given their free written consent after being informed of the purpose of the study, its conduct and its risks.
• Be affiliated with a social security scheme.
• Not participate in any other interventional study during the duration of this study.
• Have 'low' or 'moderate' IPAQ results (inactive or slightly active).